p-Terphenyl Curtisians Protect Cultured Neuronal Cells against Glutamate Neurotoxicity via Iron Chelation

Abstract

The hyperactivity of ionotropic glutamate receptors has been implicated in the development of the neuronal cell death seen in many neurodegenerative processes including ischemic stroke, traumatic brain injury, and epilepsy. Thus neuronal protection against glutamate-induced neurotoxicity is considered as an appropriate therapeutic strategy for preventing and treating neurodegenerative diseases. Whilst searching for blockers of glutamate-induced toxicity in mouse cortical cells, we isolated p-terphenyl curtisians A - D from the mushroom Paxillus curtisii. Curtisians protected cortical neurons from glutamate-induced toxicity in a dose-dependent manner. Among the glutamate receptor subtypes, curtisians were found to block NMDA receptor-mediated but not AMPA/kainate-mediated cell death. In addition, we found that curtisians exhibited potent antioxidative activity against iron-mediated oxidative damage which was generated by H₂O₂ neurotoxocity and lipid peroxidation, but no activity was detected in the superoxide, DPPH and ABTS radical scavenging systems, and in protection of N18-RE-105 cells subjected to glutamate-induced glutathione depletion. This effect was likely due to the iron chelating properties of curtisians. The iron chelation ability of curtisians was then further investigated on DNA single strand breakage (SSB) induced by the addition of iron and H₂O₂, and curtisians prevented DNA SSB like the iron chelator desferrioxamine. These results suggest that the neuroprotective action of curtisians is dependent on their ability to chelate iron as well as to block the NMDA receptor, and that in this context curtisians may be useful as neuroprotective agents against neurological disorders which result in neuronal cell death.

Paxillus curtisii - Paxillaceae - mushroom - curtisians - glutamate neurotoxicity - iron chelator

References

• 1 Dugan L L, Choi D W. Excitotoxicity, free radicals and cell membrane changes.  Ann Neurol. 1994;  35 S17-21
• 2 Choi D W, Rothman S M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.  Ann Rev Neurosci. 1990;  13 171-82
• 3 Lee J M, Zipfel G J, Choi D W. The changing landscape of ischemic brain injury mechanisms.  Nature. 1999;  399 7-14
• 4 Choi D W. Glutamate neurotoxicity in cortical cell cultures is calcium dependent.  Neurosci Lett. 1985;  58 293-7
• 5 Choi D, Koh J, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists.  J Neurosci. 1988;  8 185-96
• 6 Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity.  Nature. 1993;  364 535-7
• 7 Tan S, Sagara Y, Liu Y, Maher P, Schubert D. The regulation of reactive oxygen species production during programmed cell death.  J Cell Biol. 1998;  141 1423-32
• 8 Risher M, Schaebitz W. An overview of acute stroke therapy: past, present, and future.  Arch Int Med. 2000;  160 3196-206
• 9 Kim S R, Sung S H, Jang Y P, Markelonis G J, Oh T H, Kim Y C. E-p-Methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate.  British J Pharmacology. 2002;  135 1281-91
• 10 Seo S Y, Yun B S, Ryoo I J, Choi J S, Joo C K, Chang S Y,. et al . Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.  J Pharmacol Exp Ther. 2001;  299 377-84
• 11 Yun B S, Lee I K, Kim J P, Yoo I D. Curtisians A - D, new free radical scavengers from the mushroom Paxillus curtisii .  J Antibiotics. 2000;  53 114-22
• 12 Xie C, Markesbery W R, Lovell M A. Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium.  Free Radic Biol Med. 2000;  28 665-7
• 13 Miyamoto M, Murphy H, Schnaar R L, Coyle J T. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.  J Pharmacol and Exp Ther. 1989;  250 1132-40
• 14 Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay.  Free Radic Biol Med. 1999;  26 1231-7
• 15 Toyokuni S, Sagripanti J L. Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron.  J Inorg Biochem. 1992;  47 241-8
• 16 Gutteridge J MC, Richmond R, Halliwell B. Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine.  Biochem J. 1979;  184 469-72
• 17 Starke P E, Farber J L. Ferric ion and superoxide ions are required for the killing of cultured hepatocytes by hydrogen peroxide: evidence for the participation of hydroxyl radicals formed by an iron-catalyzed Haber-Weiss reaction.  J Biol Chem. 1985;  260 10 099-104
• 18 Sarco D, Becker J, Palmer C, Sheldon R A, Ferriero D M. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain.  Neurosci Lett. 2000;  282 113-6
• 19 Palmer C, Menzies S L, Roberts R L, Pavlic G, Connor J R. Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat.  J Neurosci Res. 1999;  56 60-71
• 20 Neilands J B. Sidrophores: structure and function of microbial iron transport compounds.  J Biol Chem. 1995;  270 26 723-6